Clinical Trial Update: Study of SGR-1505 in Mature B-Cell Neoplasms [Phase 1]

View source ↗

Summary

Schrödinger's SGR-1505 is being evaluated in a Phase 1 trial across multiple mature B-cell neoplasms and is currently recruiting. The study lists several Non-Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Lymphoplasmacytic Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• SGR-1505

Snippet

Sponsor: Schrödinger, Inc. | Conditions: Mature B-Cell Neoplasm, Non Hodgkin Lymphoma | Phase 1 | Status: RECRUITING